anoop misra

@docanoopmisra · New Delhi, India · joined 21 Aug 2011

Chairman. Fortis CDOC Hospital for Diabetes, Former Professor, Medicine, AIIMS, New Delhi, Editor-in-Chief, Diab Metab Syndr Padam Shree and BC Roy Awardee

29 071Followers

74Following

6 343Posts total

7.1KViews on collected posts

Son gönderiler

anoop misra@docanoopmisra14 Sep

My article in @IndianExpress today. Thanks to @rinkughosh A recent trial found that weekly #semaglutide helped 40.4% of children with #obesity move below the obesity threshold after 68 weeks. Such intervention but requires careful selection, and long-term monitoring. https://t.

748 views · 19 likes · 2 reposts · 0 replies Open on X →

anoop misra@docanoopmisra12 Sep

I am borrowing this nice creative made by Dr Rajiv Gupta based on my study. My thanks to him #metformin #longevity #diabetes #prediabetes https://t.co/moMb3iAAZK

1.7K views · 30 likes · 6 reposts · 0 replies Open on X →

anoop misra@docanoopmisra12 Sep

#Metformin increases #longevity in a randomised trial done by us Nicely written by @ChandnaHimani https://t.co/YVVR19R3E5 1.3K views · 34 likes · 8 reposts · 0 replies Open on X →

anoop misra@docanoopmisra9 Sep

@docanoopmisra Does this mean that a person with prediabetes will benefit from taking Metformin long-term? 34 views · 0 likes · 0 reposts · 1 replies Open on X →

anoop misra@docanoopmisra9 Sep

@docanoopmisra Interesting findings, congratulations Sir👏 48 views · 1 likes · 0 reposts · 0 replies Open on X →

anoop misra@docanoopmisra9 Sep

Our New Study Published in a High Impact Journal (IF 6.5) Metformin Increases Surrogate Markers of #Longevity in #Indians with #Prediabetes. My thoughts: "#Aging isn't just a ticking clock—it's a biological trajectory we can rewrite. #HealthyAging #Prediabetes https://

2.1K views · 24 likes · 3 reposts · 2 replies Open on X →

anoop misra@docanoopmisra8 Sep

It was great to participate in this Obesity workshop. It is encouraging to see momentum in this area. 1.1K views · 19 likes · 1 reposts · 1 replies Open on X →

Aynı büyüklükteki hesaplara karşı

Son 90 güne ait 7 gönderi, 10K–100K takipçi aralığıyla yan yana. boyutuna göre olağan erişim, çoğundan daha güçlü tepki.

Medyan görüntülenme1 135bu hesap92410K–100K için medyan

Erişim, %3.90%bu hesap3.62%10K–100K için medyan

Etkileşim, %2.21%bu hesap1.52%10K–100K için medyan

Ölçüt	Bu hesap	10K–100K için medyan	Oran
Gönderi başına medyan görüntülenme	1 135	924	1.23×
Erişim (görüntülenme ÷ takipçi)	3.90%	3.62%	1.08×
Etkileşim oranı	2.21%	1.52%	1.45×

Bu aralıktaki diğer hesaplar → Başka bir hesapla karşılaştır → Bu kıyas değerleri nasıl kuruluyor →

Growth & engagement

How the posts we collected actually performed: views and reaction rate post by post, what the audience did with them, and where the follower count goes.

Views per post

1.1K8 Sep

2.1K9 Sep

1.3K12 Sep

1.7K

74814 Sep

Last 7 collected posts, oldest on the left. The scale is logarithmic: one post can outrun the rest a hundred times over.

Engagement rate per post

1.85%8 Sep

1.51%9 Sep

2.08%

2.94%

3.14%12 Sep

2.21%

2.94%14 Sep

Reactions — likes, reposts, replies and quotes — divided by views. Median for 10K–100K accounts is 1.52%.

What the audience does

Likes77.9%127 in total

Reposts12.3%20 in total

Replies2.5%4 in total

Quotes3.7%6 in total

Bookmarks3.7%6 in total

Share of every reaction we collected for this account. Replies mean argument, reposts mean endorsement, bookmarks mean the post was worth keeping.

The follower curve appears once this account has two daily snapshots — we take one a day, and this one is on its first.

Son gönderiler

Aynı büyüklükteki hesaplara karşı

Growth & engagement

Views per post

Engagement rate per post

What the audience does

Benzer hesaplar